Altered Nuclear Transfer
Altered Nuclear Transfer
批准号:
8431435
负责人:
SHOUKHRAT M MITALIPOV
金额:
$52.91万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-01 至 2015-01-31
关键词:
AddressAdultAttentionAutologousCDX2 geneCDX2 proteinCell LineCell LineageCell NucleusCell SeparationCell TherapyCellsCharacteristicsCytoplasmDegenerative DisorderDerivation procedureDevelopmentDiseaseE-CadherinEmbryoEpigenetic ProcessEthicsEvaluationFundingGerm LayersGoalsHumanImmune responseInner Cell MassLifeMaintenanceMediatingMethodsModelingModificationMolecular ProfilingMonkeysMusOocytesOrganismOutcomePatientsPluripotent Stem CellsPrimatesProcessProductionProliferatingRegenerative MedicineRoleSchemeSmall Interfering RNASomatic CellStagingStem Cell ResearchStem cellsSymptomsSystemTechniquesTechnologyTestingTherapeuticTimeTransplantationUp-RegulationVariantViral Vectorblastocystcell typecost effectiveembryonic stem cellhuman embryonic stem cellimprovedinsightmouse modelnonhuman primatenuclear transferpre-clinicalpreimplantationpreventresearch studysomatic cell nuclear transfertooltranscription factor
中文摘要
描述(由申请人提供):该项目的目的是产生关于卵母细胞中表观遗传因子的重要新见解,这些表观遗传因子控制体细胞核移植(SCNT)后的重编程以及哺乳动物胚胎中前两个谱系(内细胞团(ICM)和滋养外胚层(TE))的形成和维持。我们的主要假设是,在卵母细胞中的关键转录因子的表达水平的实验调制将防止TE的形成,同时提高ICM谱系的生产。这些改变应该排除胚胎的形成,同时促进和增强供体细胞核重编程,这是形成可以建立多能干细胞系的单一谱系所需的。我们提出以下具体目标:目标1。用改进的ESC衍生物建立ANT小鼠模型。首先,我们将研究siRNA介导的敲低小鼠卵母细胞中Cdx 2、Tead 4和E-Cadherin对SCNT后体细胞重编程的影响。接下来,我们将研究TE失活沿着上调关键多能因子-Oct 4、Sox 2和Nanog -对ESC重编程和衍生的累积影响。目标2.定义猴卵母细胞中对TE发育至关重要的因素。在实验1中,我们将研究TEAD 4在猴卵母细胞和植入前胚胎中的存在和表达谱。接下来,我们将研究TEAD 4在猴卵母细胞和胚胎中的作用。最后,受精的TEAD 4缺陷型卵母细胞将用于ESC分离。目的3:分析关键的母体TE因子在猴SCNT后表观遗传重编程中的作用。在这个目标中,我们将应用最有前途的方法来评估ANT在猴模型中的有效性,首先创建CDX 2和TEAD 4耗尽的卵母细胞,然后进行SCNT,随后从所得的多能细胞中衍生ESC。
英文摘要
DESCRIPTION (provided by applicant): The aim of this project is to generate important new insights concerning epigenetic factors in oocytes governing reprogramming following somatic cell nuclear transfer (SCNT) and formation and maintenance of the first two lineages in mammalian embryos, the inner cell mass (ICM) and trophectoderm (TE). Our main hypothesis is that experimental modulation of expression levels for the key transcription factors in oocytes will prevent formation of the TE while enhancing the production of the ICM lineage. These alterations should preclude the formation of an embryo while promoting and enhancing donor nucleus reprogramming required for the formation of a single lineage from which pluripotent stem cell lines can be established. We propose the following specific aims: Aim 1. Establish a mouse model of ANT with improved ESC derivation. Initially, we will investigate the effect of siRNA-mediated knockdown of Cdx2, Tead4, and E-Cadherin in mouse oocytes on reprogramming of somatic cells after SCNT. Next, we will examine a cumulative impact of the TE inactivation along with upregulation of critical pluripotent factors - Oct4, Sox2, and Nanog - on reprogramming and derivation of ESCs. Aim 2. Define factors in monkey oocytes that are crucial for TE development. In Experiment 1, we will examine the presence and expression profiles of TEAD4 in monkey oocytes and preimplantation embryos. Next, we will study the role of TEAD4 in monkey oocytes and embryos by morpholino-assisted knockdown. Lastly, fertilized TEAD4-deficient oocytes will be used for ESC isolation. Aim 3: Analyze the roles of key maternal TE factors in epigenetic reprogramming after monkey SCNT. In this aim, we will apply most promising approaches to assess the validity of ANT in the monkey model by first creating CDX2 and TEAD4 depleted oocytes and then conducting SCNT and subsequently deriving ESCs from the resultant pluripotent cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reconstructing Somatic Chromosomes
-
批准号:10772559
-
项目类别:
-
资助金额:$65.99万
-
财政年份:2023
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Horizontal mtDNA Exchange
-
批准号:10356794
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2019
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Horizontal mtDNA Exchange
-
批准号:9902293
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2019
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Horizontal mtDNA Exchange
-
批准号:10584513
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2019
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Aging and Reprogramming
-
批准号:9142455
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2015
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
CORRECTING MITOCHONDIRAL GENE MUTATIONS IN HUMAN OOCYTES
-
批准号:8357848
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
ALTERED NUCLEAR TRANSFER
-
批准号:8357769
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2011
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
HISTOCOMPATIBLE PRIMATE EMBYONIC STEM CELLS (ESCS)
-
批准号:8357828
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2011
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
DERIVING OOCYTES FROM EMBRYONIC STEM CELLS (ESCS)
-
批准号:8357829
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2011
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
MITOCHONDRIAL GENE THEREAPY IN A MACAQUE MODEL
-
批准号:8357849
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2011
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Altered Nuclear Transfer
-
批准号:8013894
-
项目类别:
-
资助金额:$53.81万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
PRIMATE PLURIPOTENT CELLS FOR AUTOLOGOUS TRANSPLANTATION
-
批准号:8173333
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Gene Therapy
-
批准号:8447582
-
项目类别:
-
资助金额:$57.42万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
GENETIC ANALYSIS OF GERM CELL FORMATION
-
批准号:8173332
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Altered Nuclear Transfer
-
批准号:8212330
-
项目类别:
-
资助金额:$54.36万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Gene Therapy
-
批准号:8056813
-
项目类别:
-
资助金额:$61.86万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
DERIVING OOCYTES FROM ESCS
-
批准号:8173327
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Gene Therapy
-
批准号:8241150
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Gene Therapy
-
批准号:8644818
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
Mitochondrial Gene Therapy
-
批准号:7898222
-
项目类别:
-
资助金额:$64.35万
-
财政年份:2010
-
负责人:SHOUKHRAT M MITALIPOV
-
依托单位:
海外基金